Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
UBS
Baxter
Covington
Cipla
US Army
Julphar
Federal Trade Commission
Mallinckrodt
Fish and Richardson

Generated: February 21, 2018

DrugPatentWatch Database Preview

Lovastatin - Generic Drug Details

« Back to Dashboard

What are the generic sources for lovastatin and what is the scope of lovastatin patent protection?

Lovastatin
is the generic ingredient in three branded drugs marketed by Covis Pharma Bv, Actavis Elizabeth, Apotex Inc, Carlsbad, Lupin, Mylan, Sandoz, Sun Pharm Industries, Teva, and Merck, and is included in twelve NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Lovastatin has seven patent family members in five countries.

There are thirty-three drug master file entries for lovastatin. Forty-four suppliers are listed for this compound.
Pharmacology for lovastatin
Medical Subject Heading (MeSH) Categories for lovastatin

US Patents and Regulatory Information for lovastatin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan LOVASTATIN lovastatin TABLET;ORAL 075935-001 Dec 17, 2001 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva LOVASTATIN lovastatin TABLET;ORAL 075551-002 Dec 17, 2001 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz LOVASTATIN lovastatin TABLET;ORAL 075300-003 Dec 17, 2001 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Merck MEVACOR lovastatin TABLET;ORAL 019643-004 Dec 14, 1988 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Covis Pharma Bv ALTOPREV lovastatin TABLET, EXTENDED RELEASE;ORAL 021316-004 Jun 26, 2002 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lupin LOVASTATIN lovastatin TABLET;ORAL 078296-003 Nov 1, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva LOVASTATIN lovastatin TABLET;ORAL 075551-003 Dec 17, 2001 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Industries LOVASTATIN lovastatin TABLET;ORAL 077520-002 Apr 14, 2006 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Covis Pharma Bv ALTOPREV lovastatin TABLET, EXTENDED RELEASE;ORAL 021316-003 Jun 26, 2002 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Merck MEVACOR lovastatin TABLET;ORAL 019643-003 Aug 31, 1987 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for lovastatin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Covis Pharma Bv ALTOPREV lovastatin TABLET, EXTENDED RELEASE;ORAL 021316-001 Jun 26, 2002 ➤ Sign Up ➤ Sign Up
Covis Pharma Bv ALTOPREV lovastatin TABLET, EXTENDED RELEASE;ORAL 021316-002 Jun 26, 2002 ➤ Sign Up ➤ Sign Up
Merck MEVACOR lovastatin TABLET;ORAL 019643-002 Mar 28, 1991 ➤ Sign Up ➤ Sign Up
Covis Pharma Bv ALTOPREV lovastatin TABLET, EXTENDED RELEASE;ORAL 021316-003 Jun 26, 2002 ➤ Sign Up ➤ Sign Up
Covis Pharma Bv ALTOPREV lovastatin TABLET, EXTENDED RELEASE;ORAL 021316-004 Jun 26, 2002 ➤ Sign Up ➤ Sign Up
Merck MEVACOR lovastatin TABLET;ORAL 019643-003 Aug 31, 1987 ➤ Sign Up ➤ Sign Up
Covis Pharma Bv ALTOPREV lovastatin TABLET, EXTENDED RELEASE;ORAL 021316-004 Jun 26, 2002 ➤ Sign Up ➤ Sign Up
Covis Pharma Bv ALTOPREV lovastatin TABLET, EXTENDED RELEASE;ORAL 021316-003 Jun 26, 2002 ➤ Sign Up ➤ Sign Up
Covis Pharma Bv ALTOPREV lovastatin TABLET, EXTENDED RELEASE;ORAL 021316-001 Jun 26, 2002 ➤ Sign Up ➤ Sign Up
Covis Pharma Bv ALTOPREV lovastatin TABLET, EXTENDED RELEASE;ORAL 021316-002 Jun 26, 2002 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for lovastatin

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,440,387 Methods for determining risk of Alzheimer's disease ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Fuji
Argus Health
Queensland Health
Chubb
Fish and Richardson
Accenture
Johnson and Johnson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot